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Human keratinocytes differentiate in vitro in response
to a variety of stimuli, but neither the levels nor the
spectrum of ceramides approach those seen in vivo.
Ceramide production increases when human kera-
tinocytes are grown at an air±liquid interface, and
alterations in ceramide content occur when vitamin
C is added to air-exposed, organotypic culture sys-
tems (Ponec et al. J Invest Dermatol 109:348, 1997).
Here, we assessed whether vitamin C stimulates
sphingolipid production in human keratinocytes
independent of differentiation and air exposure.
When submerged, human keratinocytes were grown
in 1.2 mM calcium and serum-containing medium
with vitamin C (50 mg per ml) for 9 d, total lipid
content remained unchanged, but both glucosylcera-
mide and ceramide content increased. Moreover,
selected ceramide and glucosylceramide species:
i.e., nonhydroxy ceramide 2 and both a- and
w-hydroxylated sphingolipids, increased prefer-
entially [ceramide 4 (6-hydroxy-acylceramide), cera-
mide 5 (a-hydroxyceramide), ceramide 6
(4-hydroxy-a-hydroxyceramide), and ceramide 7
(6-hydroxy-a-hydroxyceramide); and acylglucosyl-
ceramide, glucosylceramide-B, and glucosylcera-
mide-D], whereas ceramide 1, ceramide 3,
glucosylceramide-C, and sphingomyelin remained
unchanged. Synthesis of the corresponding ceramide
and glucosylceramide fractions was enhanced by
vitamin C, attributable, in part, to increased cera-
mide synthase activity (over 2-fold, p= 0.01); both
serine palmitoyltransferase and glucosylceramide
synthase activities remained unaltered. Finally,
increased vitamin C-stimulated sphingolipid produc-
tion correlated with the presence of lamellar bodies
with mature internal contents, an increase in cova-
lently bound w-hydroxyceramide, and the appear-
ance of prominent, corneocyte-bound lipid
envelopes, whereas corni®ed envelope formation was
unchanged. Thus, in submerged human keratino-
cytes, vitamin C induces both increased sphingolipid
production and enhancement of permeability barrier
structural markers. Key words: epidermis/ceramide/glu-
cosylceramide/keratinocyte/vitamin C. J Invest Dermatol
117:1307±1313, 2001
T
he three major lipids in mammalian stratum corneum
(SC) are ceramides, cholesterol, and free fatty acids
(FFA), which are organized into extracellular bilayers
that subserve the epidermal permeability barrier
function (Elias and Menon, 1991). Prior studies have
provided indirect and direct evidence for the importance of
epidermal ceramides for the barrier: First, mammalian epidermis
synthesizes unusually large amounts of ceramides (Schoephoerster et
al, 1985; Uchida et al, 1988), which ultimately comprise 50% of SC
lipids by weight. Second, epidermal ceramides comprise a
heterogeneous mixture of molecules, including some species that
are unique to the epidermis; e.g., w-hydroxyceramide (w-OH-
Cer) and linoleate-containing w-(o-linoleoyl)-Cer (Wertz and
Downing, 1983b; Bowser et al, 1985). w-OH-Cer are the primary
lipids that are covalently attached to the corni®ed envelope (CE)
(Wertz and Downing, 1986, 1987, 1989a), forming the so-called
corneocyte lipid envelope (CLE) (Wertz et al, 1989b; Downing,
1992; Elias et al, 2000), a structure that is required for normal
barrier function (Behne et al 2000). Third, epidermal ceramide
synthesis is stimulated in parallel with barrier recovery following
either acute or chronic barrier perturbations (Holleran et al, 1991a,
b), and epidermal ceramide synthesis is required for normal barrier
recovery after such perturbations (Holleran et al, 1991b). Finally,
alterations in the content and distribution of epidermal ceramide
occur in skin diseases that display barrier abnormalities, such as
atopic dermatitis (Imokawa et al, 1991; Yamamoto et al, 1991) and
psoriasis (Motta et al, 1993). Therefore, it is likely that both total
ceramide content and the molecular heterogeneity of ceramides are
important for normal permeability barrier homeostasis. Hence,
identi®cation of factors that in¯uence the production of ceramides
could contribute both to a further understanding of normal barrier
homeostasis, and to potential therapeutic interventions that could
modulate barrier formation.
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Cultured human keratinocytes (CHK) and cultured murine
keratinocytes have been employed extensively to investigate
epidermal growth and differentiation. It is well established that an
increase in exogenous calcium stimulates keratinocyte differenti-
ation in vitro (Hennings et al, 1980). Moreover, when submerged
cultures are grown at an air±medium interface, they generate a still
more-differentiated, ``organotypic'' phenotype, including more
abundant ceramide content and a partially competent barrier
(Madison et al, 1989; Fartasch and Ponec, 1994; Bouwstra et al,
1995; VicanovaÂ et al, 1998). Such lifted cultures, when they are
supplemented with vitamin C (Vit C), demonstrate an increase in
ceramides as a percentage of total lipids, as well as changes in the
spectrum of ceramide and glucosylceramide fractions to more
closely resemble ceramide content and distribution in vivo; i.e., an
increase in more polar ceramide species (Ponec et al, 1997).
Whether Vit C affects sphingolipid synthesis, independent of air
exposure and/or the extent of differentiation, has not been
investigated. In this study, we show that the addition of a
supraphysiologic dose of Vit C to postcon¯uent CHK, grown in
high calcium and serum stimulates bulk sphingolipid production,
with enhancement of selected ceramide and glucosylceramide
species, particularly of a- and w-hydroxylated sphingolipids. The
net result is a spectrum of sphingolipids that closely resembles that
observed in vivo. This stimulation of sphingolipid production is
accompanied, in turn, by increased formation of covalently bound
lipids, as well as enhanced lamellar body (LB) production, secretion,
and postsecretory membrane structural reorganization, markers of
permeability barrier formation. Finally, we show that these
biochemical and morphologic changes may be attributable to Vit
C-induced stimulation of the enzyme, ceramide synthase, the ®nal
step in ceramide synthesis.
MATERIALS AND METHODS
Cell culture Human epidermis was isolated from newborn foreskins by
incubation in Dispase, and a suspension of keratinocytes was obtained by
incubation in 10 mM ethylenediamine tetraacetic acid and subsequent
trypsinization as previously described (Pittelkow and Scott, 1986).
Second passage cells were plated on to 100-mm plastic dishes in serum-
free keratinocyte growth medium (Cascade Biologics, Portland, OR),
containing 0.07 mM calcium, and grown to 90±100% con¯uence. The
medium then was switched to Dulbecco's modi®ed eagle's medium and
Ham F-12 (2:1, vol/vol), modi®ed from 3:1, vol/vol (as per Sando et al,
1996), containing 1.2 mM calcium, supplemented with 10% fetal bovine
serum, 10 mg insulin per ml, and 0.4 mg hydrocortisone per ml.
Immediately after switching the medium, either Vit C (®nal
concentration of 50 mg per ml in phosphate-buffered saline) (Ponec et al,
1997) or vehicle (phosphate-buffered saline) was added to parallel
cultures, and cells were cultured for 9 d with medium changes every
other day. Preliminary studies also demonstrated that Vit C
concentrations below 50 mg per ml induced lesser changes in ceramide
and glucosylceramide production. Higher concentrations of Vit C (i.e.,
100±500 mg per ml) did not further increase sphingolipid production.
Lipid analysis Total lipids were extracted from CHK and from
sunburn scale of normal human subjects (n = 3), as described previously
(Bligh and Dyer, 1959), and separation of individual lipid species was
achieved by high-performance thin-layer chromatography (HPTLC),
followed by quantitation by scanning densitometry as described
previously (Holleran et al, 1991b, 1997), as modi®ed (Ponec and
Weerheim, 1990). Assignment of ceramides and glucosylceramides and
their nomenclature are based on their comparative mobilities vs known
standards (Wertz and Downing, 1983c). a-hydroxy- and nonhydroxy-
ceramide and nonhydroxy-glucosylceramide standards were from Sigma
(St Louis, MO). Phospholipids were separated using chloroform/
methanol/acetic acid/water (50:30:8:4, vol/vol/vol). Triglycerides and
cholesterol were fractionated by development in n-hexane/diethyl ether/
acetic acid (80:20:1, vol/vol/vol). Covalently bound lipids were isolated
using the method of Wertz et al (1989a), and resultant ceramide fractions
were quantitated by HPTLC-scanning densitometry, as above.
To assess rates of lipid synthesis, cells were incubated with 100 mM
sodium acetate (5 mCi, [14C]sodium acetate; Amersham, Arlington
Heights, IL) for 8 h. To measure hydroxyglucosylceramide (OH-GlcCer)
and OH-Cer synthesis, lipids extracts ®rst were fractionated on an
aminopropyl column, following elution ®rst of phospholipids with n-
hexane, by elution with chloroform±isopropanol (2:1, vol/vol) to obtain
ceramides. Further fractionation of ceramides were performed by
HPTLC as above. For analysis of newly synthesized amide-linked fatty
acids of glucosylceramides and ceramides, the combined glucosylcera-
mide/ceramide fraction was scraped from the plate, hydrolyzed with
aqueous methanolic HCl, treated with 2,2¢-dimethoxypropane, contain-
ing methanolic HCl, and the fatty acid methyl esters were separated by
HPTLC [in n-hexane/diethylether/acetic acid (70:30:1, vol/vol/vol), as
previously reported (Wertz and Downing, 1983a)], and measured with a
Beckman LS-1800 scintillation counter.
Serine palmitoyltransferase, glucosylceramide synthase, and
ceramide synthase activities For the enzyme activity determinations
below, CHK were ®rst washed with phosphate-buffered saline (3 3),
harvested with a cell scraper, homogenized (15 s 3 3) using a Polytron
PCU2 Tissue Homogenizer (Kinematica, GmbH, Lucerne, Switzerland),
and then sonicated (35%, 10 s 3 2) using a Fisher Sonic dismembranator
(Artec Corp, Farmingdale, NY). Protein content of the resultant
homogenates were determined using BCA protein assay method (Pierce,
Rockford, IL), using bovine serum albumin as standard. Our procedures
for the isolation and quantitation of serine palmitoyltransferase from
cultured keratinocytes have been described in detail elsewhere (Holleran
et al, 1990). The reaction product, [3H]-3-ketodihydrosphinganine was
isolated and counted, as above. The assay for glucosylceramide synthase
activity was described recently (Chujor et al, 1998). Incorporation of
[14C]uridine diphosphate glucose (American Radiolabeled Chemical, St
Louis, MO; Spec. Act. 20,000 dpm per nmol) into glucosylceramides
was determined by counting, as above. The assay for ceramide synthase
was described recently (Wang and Merrill, 2000). Brie¯y, CHK
homogenates (1.5 mg of protein) were incubated with 50 mM
[14C]lignoceric acid (C24:0) (American Radiolabeled Chemical, Spec.
Act. 9±10,000 dpm per nmol), 1 mM coenzyme A, 5 mM adenosine
triphosphate, 1 mM NADPH, 1 mM NADH and 50 mM HEPES
buffer, pH 7.4 at 37°C (60 min). Enzyme reactions were terminated by
adding chloroform±methanol (1:2, vol/vol). Incorporation of
[14C]lignoceric acid into the amide-linked fatty acid of ceramides was
analyzed as described above.
CE formation The formation of CE as a marker for the terminal
differentiation of keratinocytes was determined by the method of King
et al (1986), as previously modi®ed (Pillai et al, 1988). CHK were
incubated in Dulbecco's modi®ed eagle's medium-Ham F-12 as
described above containing [35S]-L-methionine (1.5 mCi medium per ml,
ICN Radiochemicals Inc, Irvine, CA) for 46 h. The cells were rinsed
with phosphate-buffered saline and cultured in Dulbecco's modi®ed
eagle's medium-Ham F-12 containing 10 mM ionomycin for 2 h. The
cross-linked, 2% sodium dodecyl sulfate and 25 mM dithiothreitol-
insoluble pellets were collected on ®lters and quantitated by liquid
scintillation spectroscopy.
Electron microscopy CHK samples were ®rst ®xed in situ by the
addition of half-strength Karnovsky's ®xative to the Petri dish for 1 h
(room temperature), transferred to a glass tube, further ®xed overnight
(4°C), and post®xed in both ruthenium tetroxide and 2% aqueous
osmium tetroxide, both containing 1.5% potassium ferrocyanide, as
previously described (Hou et al, 1991). After ®xation, all samples were
dehydrated in graded ethanol solutions, and embedded in an Epon-epoxy
mixture. Ultrathin sections were examined, with or without further
contrasting with lead citrate, in an electron microscope (Zeiss 10A, Carl
Zeiss, Thornwood, NY) operated at 60 kV. Quantitative morphometry
(i.e., counting of LB numbers per cell) was performed on ®ve separate
®elds from ®ve control and nine Vit C-treated sample sections; the
numbers of LB were counted in a total of 47 control cells and 86 Vit C-
treated cells.
Statistical analysis Statistical analyses were performed using a Mann±
Whitney test or an unpaired Student's t test, as appropriate.
RESULTS
Glucosylceramide and ceramide content increase with Vit C
supplementation We ®rst determined the effects of 9 d of Vit C
supplementation (50±500 mg per ml) on total lipid, protein, and
DNA content in submerged, postcon¯uent CHK. Nine days of Vit
C treatment did not alter total cellular lipid, protein, or DNA
content as compared with vehicle controls (not shown). In contrast,
the total content of both glucosylceramide and ceramide content
increased signi®cantly in 9 d Vit C-supplemented vs control CHK.
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The total glucosylceramide content of Vit C-treated CHK
increased 1.8-fold vs control levels after 9 d (49.96 6 SD 0.80 vs
28.95 6 0.20 mg per 100 mm cultured dish, respectively; p
< 0.0002). Glucosylceramides in Vit C supplemented vs control
CHK could be separated into four major fractions by HPTLC
[acylGlcCer (GlcCer-A; the most hydrophobic component),
GlcCer-B, GlcCer-C, and GlcCer-D (the most hydrophilic
component)] (Wertz and Downing, 1983c; Wertz et al, 1984).
GlcCer-A, GlcCer-B, and GlcCer-D, but not GlcCer-C, increased
signi®cantly in Vit C-treated vs vehicle-treated CHK (Fig 1A; i.e.,
2.79-fold, 1.46-fold, and 2.09-fold; p < 0.001 vs vehicle,
respectively).
The total ceramide levels in Vit C-treated cells also increased
1.7-fold over control levels after 9 d (i.e., 66.54 6 6.50 vs
40.50 6 4.54 mg per dish; p < 0.02). Moreover, speci®c ceramide
species increased, including Cer 2 [N-nonhydroxyacyl sphingosine
(Cer-NS); 1.23-fold, p < 0.02], Cer 4 [N-(O-linoleoyl) w-
hydroxyacyl dihydroxysphingosine (Cer-EOH); 5.6-fold, p
< 0.001], and Cer 5 [N-a-hydroxyacyl sphingosine (Cer-AS);
2.87-fold, p < 0.01], whereas Cer 1 [N-(O-linoleoyl) w-hydro-
xyacyl sphingosine (Cer-EOS) and Cer 3 [N-nonhydroxyacyl
phytosphingosine (Cer-NP)] levels did not change (Fig 1B).
[Ceramide nomenclature as per Motta et al (1993) and Robson et
al (1994).] Neither Cer 6 nor 7 were detected in control
preparations, but both became prominent in Vit C-treated cells
(Fig 1B). Finally, sphingomyelin content did not change following
9 d of Vit C supplementation (not shown).
Vit C increases the synthesis of bulk and speci®c sphingo-
lipids We next studied the effects of Vit C supplementation on
glucosylceramide and ceramide synthesis. First, incorporation of
[14C]acetate into both total glucosylceramides and total ceramides
increased signi®cantly (i.e., 3.55-fold and 1.76-fold, respectively; p
< 0.001 and 0.01), changes that mirrored the Vit C-induced
alterations in lipid content (cf. Fig 1). The corresponding,
individual glucosylceramide species also increased signi®cantly
(Fig 2A): GlcCer-A, 5.94-fold (p < 0.001); GlcCer-B, 3.03-fold
(p < 0.0001); and GlcCer-D, 3.72-fold (p < 0.0001). But as with
the lipid content (above), the increase in GlcCer-C production did
not achieve statistical signi®cance (Fig 2A). Vit C also increased
the synthesis of the four most polar ceramide fractions (Fig 2B);
i.e., Cer 4±7 (e.g., Cer 4, 5.08-fold, p < 0.01; Cer 5, 2.59-fold, p
< 0.01). In fact, Cer 6 and 7 syntheses were only evident in Vit C-
treated CHK (Fig 2B). Finally, consistent with the content studies,
sphingomyelin synthesis also was not altered by Vit C
supplementation (Fig 2C cf. Fig 1B). These results indicate that
the Vit C-induced changes in sphingolipid content re¯ect increased
synthesis of bulk and speci®c ceramide species.
A characteristic of epidermal sphingolipids is that the more polar
glucosylceramide and ceramide species are enriched in a- and
Figure 2. Vit C stimulates glucosylceramide,
ceramide, and cholesterol syntheses in
normal human keratinocytes cultured in a
submerged system. Cells were cultured in
serum-containing medium with or without 50 mg
Vit C per ml for 9 d. To assess lipid synthesis,
cells were incubated with [14C]sodium acetate for
8 h. Panel A:glucosylceramide; panel B:ceramide;
panel C:phospholipids (LPC, lysophosphatidyl-
choline; SM, sphingomyelin; PC, phosphatidyl-
choline; PS, phosphatidylserine; PI, phos-
phatidylinositol; PE, phosphatidylethanolamine);
panel D:cholesterol and triacylglycerol. Values
represent mean [14C]acetate incorporation into
lipids per 100 mm cultured dish (n = 3; 6 SD).
*p < 0.01; **p < 0.001; ***p < 0.0001 each vs
vehicle-treated control.
Figure 1. Vit C increases glucosylceramide
and ceramide content in normal human
keratinocytes cultured in a submerged
system. Cells were cultured in serum-containing
medium with or without 50 mg Vit C per ml for
9 d. Panel A:glucosylceramides; panel B:ceramides.
Values represent mean mg of sphingolipids per
100 mm cultured dish (n = 3; 6 SD). *p < 0.02;
**p < 0.01; ***p < 0.001, each vs vehicle-treated
control, respectively.
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w-hydroxylated, amide-linked fatty acids. We next assessed
whether Vit C supplementation enhances [14C]acetate incorpor-
ation into hydroxylated vs nonhydroxylated, amide-linked fatty
acids of these sphingolipid species. Whereas Vit C stimulated the
incorporation of radiolabel into all nonhydroxylated, amide-linked
fatty acids in sphingolipids by approximately 1.4-fold over vehicle
control values (i.e., 14.8 6 0.5 vs 10.2 6 2.0 CPMx10,000 per
100 mm dish; p < 0.05), the synthesis of hydroxylated fatty acid-
containing ceramide increased still further (i.e., a-OH fatty acid:
7.5-fold, 1.75 6 0.17 vs 0.5 6 0.15, p < 0.0001; and w-OH fatty
acid: 3.5-fold, 3.5 6 0.2 vs 0.47 6 0.08; p < 0.001). These results
show that Vit C stimulates not only sphingolipid production, but
also the preferential formation of hydroxylated glucosylceramide
and ceramide species.
Finally, we next assessed whether the synthesis of nonsphingo-
lipid lipids also changes with Vit C supplementation. Vit C
increased cholesterol synthesis 1.5-fold (Fig 2D; p < 0.01), and
decreased triacylglycerol (Fig 2D; p < 0.01) and phosphatidylcho-
line production (» 30% below control; Fig 2C). Together, these
results demonstrate that Vit C supplementation modulates the
synthesis of other epidermal lipids to achieve a pro®le that further
re¯ects SC lipid pro®les (Lampe et al, 1983a, b).
Vit C stimulates ceramide synthase To assess the metabolic
step(s) at which Vit C might exert its effects on sphingolipid
synthesis, we next measured the activities of three key enzymes of
epidermal sphingolipid metabolism (i.e., serine palmitoyltransferase,
ceramide synthase, and glucosylceramide synthase) following Vit C
supplementation. Whereas neither serine palmitoyltransferase nor
glucosylceramide synthase activities increased during the 9 d of Vit
C treatment (Table I), ceramide synthase activity increased
signi®cantly in Vit C-treated cells vs vehicle-treated cells (2.3-
fold; p < 0.01). (Activity includes increased formation of both a-
and w-OH-containing, as well as nonhydroxylated ceramide
species.) These results show that the N-acylation of
dihydrosphingosine by ceramide synthase, leading to the
generation of ceramides, is a step in ceramide production that is
upregulated by Vit C.
Vit C increases the amount of w-OH-Cer bound to the
CE To evaluate the potential consequences of increased
sphingolipid production by Vit C treatment for epidermal
structure and function, we ®rst determined the levels of w-OH-
Cer that form a modi®ed membrane bilayer, external to the CE.
Although the levels of total protein-bound (i.e., base-hydrolyzable)
lipids were elevated at 9 d (1.8-fold over controls; p < 0.02), a
further increase was evident in 12 d Vit C-treated cells (4.70-fold vs
levels in control cells; p < 0.001) (Table II). In addition, although
only N-w-OH acylsphingosine was observed in control cells at
12 d, N-w-OH acyldihydroxysphingosine and w-OH FFA also
were contained in Vit C-treated cells. As the backbone structures of
N-w-OH acylsphingosine and N-w-OH acyldihydroxysphingosine
are the same as Cer 1 and Cer 4, respectively, an increase in N-w-
OH acyldihydroxysphingosine could be due to Vit C-induced
production of Cer 4 (cf. Figure 1B); however, the ratio of Cer A
to Cer B in Vit C-treated CHK is lower in human SC (i.e., CHK,
4.1 vs SC 1.7±2.2) (Wertz et al, 1989a; Elias et al, 2000). In
addition, w-OH-GlcCer, which are precursors of N-w-OH
acylsphingosine and N-w-OH acyldihydroxysphingosine, also
increased in Vit C-treated cells. Finally, the bound
nonhydroxylated fatty acids RM also increased in Vit C-treated
cells (1.48-fold vs levels in control cells: 16.97 6 0.65 vs
11.37 6 0.36 mg per 100 mm culture dish, respectively; p
< 0.001). Together, these results demonstrate that Vit C enhances
the amount of ceramide bound to the CE, even under submerged
conditions.
Vit C treatment increases LB production and secretion, and
CLE formation We next assessed whether the increased
sphingolipid production in Vit C supplemented cultures is linked
to permeability barrier formation. Nine day postcon¯uent CHK
treated with vehicle or serum alone exhibited few LB, and little or
no secreted lamellar contents (not shown). In contrast, CHK
treated for 9 d with Vit C demonstrated numerous suprabasal cells
with large numbers of LB, but few of these organelles exhibited
replete, internal lamellar contents (Fig 3, panel B, arrows).
Morphometric analysis of 9 d cultures revealed signi®cantly
increased LB numbers (p < 0.003) in Vit C-treated vs control
cells; i.e., 4.3 6 0.5 vs 2.3 6 0.6 LB per cell for Vit C and control
samples, respectively. Although foci of newly secreted lamellae also
occurred in the 9 d Vit C cultures (Fig 3, panel A, arrows), no
mature, lamellar structures were evident. Prolongation of
postcon¯uent growth from 9 to 12 d resulted both in a further
ampli®cation in the number of cytosolic LB, and the appearance of
a large proportion of organelles with replete internal contents (not
shown); however, mature extracellular lamellar membrane
structures still were not evident at 12 d (not shown). In contrast,
whereas 14 d cultures displayed no further increase in LB numbers
or contents, these cultures frequently displayed extracellular
Table I. In¯uence of Vit C on sphingolipid synthetic
enzymesa
Enzyme activity
(pmol per mg protein per min)
Control +Vit C
Serine palmitoyltransferase 148.5 6 12.20b 117.5 6 24.70
Ceramide synthase 0.50 6 0.05 1.15 6 0.06c
Glucosylceramide synthase 30.80 6 1.88 27.52 6 0.44
aCells were cultured serum-containing medium without (Control) or with Vit
C for 9 d.
bValues represent mean 6 SD (n = 3±4).
cp < 0.01 vs control.
Table II. Vit C increases the amount of CLEa
Covalently bound lipidb
N-w-OH-Cer-Ac w-OH-Cer-B w-OH-GlcCer w-OH FFA Total
Control 1.24 6 0.31 NDd trace trace 1.17 6 0.24
Vit C 4.35 6 0.45 1.05 6 0.12 0.47 6 0.08 1.00 6 0.07 5.48 6 0.52e
aCells were cultured serum-containing medium with or without Vit C for 12 d.
bCovalently bound lipids recovered following base-hydrolysis (see Materials and Methods); values represent the mean
mg per 100 mm cultured dish 6 SD (n = 3).
cDe®nitions: w-OH-Cer-A: N-w-OH acyl sphingosine, w-OH-Cer-B: N-w-OH acylhydroxy-sphingosine (Robson et al, 1994), w-OH-GlcCer: w-OH acylglucosyl-
ceramide (Doering et al, 1999a; Doering et al, 1999b; Uchida et al, 1999).
dNot detected.
ep < 0.001 vs control.
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lamellar bilayers (not shown). These results show that Vit C
supplementation leads not only to increased sphingolipid
production, but also to apparent downstream accumulation of
sphingolipids in barrier-related structures.
Although some CLE became evident around corneocytes in
both control and Vit C-supplemented cultures by day nine, these
structures became much more prominent in day 12 and 14 cultures
(not shown). Together, these results show that the Vit C stimulated
increase in covalently bound lipids is re¯ected in enhanced CLE
formation. Finally, as ceramide itself can induce differentiation
(Wakita et al, 1994), we next assessed whether Vit C treatment
simultaneously produced changes in CHK differentiation; how-
ever, Vit C treatment did not signi®cantly increase CE formation
(Vit C: 205 6 8 vs vehicle: 173 6 28 cpm per mg protein; not
signi®cant). These results show that the Vit C-induced increase in
sphingolipid synthesis is not linked either to prior or concurrent
changes in CHK differentiation, re¯ected by CE formation.
DISCUSSION
The extracellular lamellar membranes in the SC of mammalian
epidermis, which are enriched in cholesterol, ceramides, and FFA,
are an essential component of the epidermal permeability barrier
(Elias and Menon, 1991). Among these lipids, ceramides constitute
nearly 50% of the lipid mass in the SC (Elias and Menon, 1991).
Although the molecular structures of epidermal glucosylceramides
and ceramides have been studied extensively (Wertz and Downing,
1983b, >c; Abraham et al, 1985; Bowser et al, 1985; Ponec et al,
1988; Uchida et al, 1988, 2000; Hamanaka et al, 1989; Motta et al,
1993; Robson et al, 1994), the mechanisms that regulate ceramide
synthesis still are not known. The heterogeneity of ceramide
structures also plays a crucial part in the formation of lamellar
membrane structures (Bouwstra et al, 1998). The formation of these
lamellar structures occurs in four sequential steps: (i) the synthesis of
these lipids as their polar precursors (e.g., glucosylceramides and
sphingomyelin); (ii) the packaging of these lipids into nascent LB;
(iii) the extrusion of LB contents into the extracellular spaces
between the stratum granulosum and SC; and ®nally (iv) the
processing of these secreted lipids into their products, leading to the
formation of bilayer structures. Although these steps parallel
keratinocyte differentiation, sphingolipid production and LB
formation/secretion remain very low in immersed keratinocyte
cultures, even when such cultures display ample evidence of
differentiation (Pillai et al, 1988; Ponec et al, 1988; Fartasch and
Ponec, 1994).
Over the past decade, organotypic culture systems in which
submerged keratinocytes are lifted to the air±medium interface,
have been developed to replicate epidermis in vitro further. Indeed,
such reconstituted organotypic models display variable sphingolipid
production, LB formation, and appearance of extracellular lamellar
bilayers (Ponec et al, 1988; Williams et al, 1988; Madison et al,
1990; Boyce and Williams, 1993; Fartasch and Ponec, 1994). A
further increase in sphingolipid and LB production occurs when
the external humidity surrounding organotypic cultures is lowered
further (Mak et al, 1991). Likewise, organ cultures of fetal skin
accelerate barrier formation, attributable to increased sphingolipid
production and LB generation, when they are grown at an air±
medium interface (Hanley et al, 1997). Although these studies
suggest that increased sphingolipid/LB production is linked
speci®cally to a reduction in external humidity, LB also occur in
follicular epithelia (Schmitz and MuÈller, 1991), in epidermal
inclusion cysts (Madison et al, 1987), in mucosal epithelia
(Schmitz and MuÈller, 1991), and in marine mammalian epidermis
(Menon et al, 1986), where stimulation from a lowered external
humidity is not operative. Furthermore, in these air-exposed
culture systems, neither the total sphingolipid content nor the
distribution of ceramides/glucosylceramides achieves that found
Figure 3. Vit C increases the number of LB
and extrusion of their contents. Electron
micrographs of normal human keratinocytes
cultured in serum-containing medium with 50 mg
Vit C per ml for 9 d. Panel A: foci of newly
secreted lamellae are evident, whereas mature
extracellular lamellar structures were not present.
Panel B: abundant number of LB were present in
the cytosol of cells. Panel A, ruthenium tetroxide;
panel B, osmium tetroxide; Mag bars = 0.25 mm.
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in vivo. Hence, other factors, such as speci®c enzyme cofactor(s) or
activators of key transcription factors, could regulate or coregulate
sphingolipid/LB production. Recently, supplementation of an
organotypic culture system with Vit C was shown both to increase
total ceramide content and to alter ceramide distribution to more
closely mirror that observed in vivo (Ponec et al, 1997); however,
these studies left unanswered whether Vit C increases sphingolipid
production in relation to differentiation, air exposure, and/or by
unrelated mechanism(s). We show here that increased production
of epidermal-type ceramides and glucosylceramides in Vit C-
supplemented CHK occurs independently of air exposure; i.e., in
submerged cultures. Moreover, although keratinocyte differenti-
ation per se reportedly stimulates ceramide/glucosylceramide syn-
thesis (Madison et al, 1989; Sando et al, 1996), we show here that
CE formation, a marker of keratinocyte terminal differentiation
(Sun and Green, 1976; Pillai et al, 1988), does not change
signi®cantly with Vit C treatment. Thus, the observed, Vit C-
induced elevation in ceramide and glucosylceramide syntheses is
not likely to be linked to a prior or concurrent increase of
keratinocyte differentiation. Instead, Vit C treatment appears to
stimulate sphingolipid production directly, increasing not only bulk
sphingolipids through an increase in ceramide synthase, but
particularly those sphingolipid subclasses that contain a- and w-
hydroxylated species. Some nonhydroxylated sphingolipids also
increased with Vit C treatment, but to a lesser extent. The net
result is a spectrum that closely resembles that in Vit C-treated
organotypic cultures (Ponec et al, 1997).
The basis for the overall increase in ceramide production appears
to be stimulation in the activity of a key enzyme in ceramide
generation; i.e., ceramide synthase. Whether regulation occurs at a
transcriptional and/or post-translational level could not be deter-
mined, because the responsible gene for ceramide synthase has yet
to be cloned. Whereas it is possible that the reducing environment,
resulting from Vit C treatment, might favor post-transcriptional
regulation of ceramide synthesis, it is important to note that
addition of other reducing agents, such as vitamin E, did not
stimulate sphingolipid production in organotypic CHK (Ponec et
al, 1997). Thus, it is more likely that Vit C is a speci®c cofactor for
ceramide synthase, as it is for key enzymes of collagen synthesis
(Barnes and Kodicek, 1972). In contrast, Vit C treatment did not
appear to alter either serine palmitoyltransferase or glucosylcer-
amide synthase activities, two other key enzymes of ceramide and
glucosylceramide synthesis, respectively. It is intriguing that the
activity of serine palmitoyltransferase, reported as the rate-limiting
step in epidermal sphingolipid production (Holleran et al, 1991a,
1991b), was unaffected by Vit C supplementation. This result
suggests either that constitutive levels of these enzymes may suf®ce
to accommodate increased ceramide and glucosylceramide pro-
duction (i.e., via substrate regulation), or that keratinocyte culture
conditions may alter the relative importance of contributing
enzymes in the sphingolipid synthetic pathway. Both of these
possibilities merit further investigation.
Vit C also could in¯uence other relevant enzymes nonspeci®c-
ally as a reducing agent. Such activity could account for the
disproportionate increase in a- and w-OH-Cer levels observed in
Vit C-treated cultures. Previous structural studies have shown that
the amide-linked fatty acids of Cer 4 through 7 are hydroxylated at
speci®c positions (Abraham et al, 1985; Bowser et al, 1985; Robson
et al, 1994; Stewart and Downing, 1999). As Vit C increased not
only the production of hydroxylated sphingolipids, but also the
levels of certain nonhydroxylated sphingolipids its effects on fatty
acid hydroxylation appear to be distinct from those on ceramide
synthase.
The proportion of three major lipid species, i.e., ceramides,
cholesterol, and FFA, is important for the formation of lamellar
membrane structures in mammalian SC, and the formation of the
barrier to water loss (Bouwstra et al, 1996; Man et al, 1996).
Addition of serum and epidermal growth factor to organotypic
keratinocyte cultures both elevates triacylglycerol, and reduces
ceramide and FFA levels (Gibbs et al, 1997). Conversely, Vit C
supplementation, while increasing ceramides, also reduced triacyl-
glycerol in an organotypic model (Ponec et al, 1997). As Vit C
induced similar normalization of triacylglycerol levels under
submerged conditions (this study), this effect of Vit C appears
independent of air exposure. Although phospholipids are known to
be key precursors in the generation of SC FFA (Mao-Qiang et al,
1995), the role of triglycerides in this process remains unresolved.
Thus, the present results suggest that Vit C may alter epidermal or
SC lipase activity leading to the further normalization of barrier
lipid composition.
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